Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 OverviewCyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CYCCP.
Quarterly EBIT
-$197.00
As of Mar 31, 2026
Annual EBIT (TTM)
-$8.43M
↓ 353.26% YoY
Trailing 12 months ending Mar 31, 2026